Literature DB >> 22905989

Epigenetic drugs for Alzheimer's disease.

Jacob Peedicayil.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 22905989      PMCID： PMC3612735          DOI： 10.1111/j.1365-2125.2012.04444.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Crosstalk between aging and the epigenome.

Authors:  Hanneke Vlaming; Fred van Leeuwen
Journal:  Epigenomics       Date:  2012-02       Impact factor: 4.778

2.  Role of epigenetics in pharmacotherapy, psychotherapy and nutritional management of mental disorders.

Authors:  J Peedicayil
Journal:  J Clin Pharm Ther       Date:  2012-03-26       Impact factor: 2.512

Review 3.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Authors:  Salvatore Salomone; Filippo Caraci; Gian Marco Leggio; Julia Fedotova; Filippo Drago
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

4.  Epigenetic mechanisms in Alzheimer's disease.

Authors:  M Daniilidou; M Koutroumani; M Tsolaki
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 5.  Epigenetic treatments for cognitive impairments.

Authors:  Jeremy J Day; J David Sweatt
Journal:  Neuropsychopharmacology       Date:  2011-05-18       Impact factor: 7.853

Review 6.  Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

Authors:  Ted Abel; R Suzanne Zukin
Journal:  Curr Opin Pharmacol       Date:  2008-02       Impact factor: 5.547

Review 7.  Epigenetics, oxidative stress, and Alzheimer disease.

Authors:  Nasser H Zawia; Debomoy K Lahiri; Fernando Cardozo-Pelaez
Journal:  Free Radic Biol Med       Date:  2009-02-23       Impact factor: 7.376

Review 8.  Targeting HDACs: a promising therapy for Alzheimer's disease.

Authors:  Ke Xu; Xue-Ling Dai; Han-Chang Huang; Zhao-Feng Jiang
Journal:  Oxid Med Cell Longev       Date:  2011-09-20       Impact factor: 6.543
  8 in total
  2 in total

1.  Epigenetic drugs for Alzheimer's disease: hopes and challenges.

Authors:  Filippo Caraci; Gian Marco Leggio; Filippo Drago; Salvatore Salomone
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

2.  Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer's disease.

Authors:  Hui Liu; Weidong Le
Journal:  Transl Neurodegener       Date:  2014-03-20       Impact factor: 8.014
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.